These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2474417)
21. Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites. Uehara T; Yoshida H; Fukuhara M; Yoshida M; Motoi N; Sugawara S; Sone M; Arai Y; Tamura K; Uno M; Ishikawa M; Kato T Gynecol Oncol; 2020 May; 157(2):398-404. PubMed ID: 32063274 [TBL] [Abstract][Full Text] [Related]
22. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors]. Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. Tashiro Y; Yonezawa S; Kim YS; Sato E Hum Pathol; 1994 Apr; 25(4):364-72. PubMed ID: 8163269 [TBL] [Abstract][Full Text] [Related]
26. [Clinical aspects and pathology of granulosa cell tumors. A single case report]. Wessel J; Minguillon C Zentralbl Gynakol; 1992; 114(3):136-40. PubMed ID: 1595308 [TBL] [Abstract][Full Text] [Related]
27. Erythropoietin is detectable in the ascitic fluid in patients with ovarian tumors. Stefanovic V; Pakarinen P; Alfthan H; Stenman UH; Leminen A; Pociuviene J; Riska A; Loukovaara M Int J Gynecol Cancer; 2012 Nov; 22(9):1470-3. PubMed ID: 23027039 [TBL] [Abstract][Full Text] [Related]
28. [Histochemical analysis of uterine cervical adenocarcinoma with reference to mucosubstances and distribution of CEA, CA125 and CA19-9]. Maruyama C; Yamamichi N; Konishi F Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):429-36. PubMed ID: 3163714 [TBL] [Abstract][Full Text] [Related]
29. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611]. Huang JS Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538 [TBL] [Abstract][Full Text] [Related]
30. Marker profile of mesothelial cells versus ovarian carcinoma cells. van Niekerk CC; Jap PH; Thomas CM; Smeets DF; Ramaekers FC; Poels LG Int J Cancer; 1989 Jun; 43(6):1065-71. PubMed ID: 2659540 [TBL] [Abstract][Full Text] [Related]
31. Peritoneal fluid cytology in serous borderline tumours of the ovary. Stewart CJ; Kennedy JH Cytopathology; 1998 Feb; 9(1):38-45. PubMed ID: 9523127 [TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)]. Kato T; Nishimura H; Hamai J; Yamabe T; Nakajima H; Nakano T; Noda K; Teshima K; Suzuki H; Ueda G Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2338-45. PubMed ID: 3007640 [No Abstract] [Full Text] [Related]
33. A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers. Horowitz AT; Treves AJ; Voss R; Okon E; Fuks Z; Davidson L; Biran S Oncology; 1985; 42(5):332-7. PubMed ID: 2412195 [TBL] [Abstract][Full Text] [Related]
34. Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2. van Dam PA; Lowe DG; Watson JV; Jobling TW; Chard T; Shepherd JH Cancer; 1991 Jul; 68(1):169-77. PubMed ID: 2049739 [TBL] [Abstract][Full Text] [Related]
35. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma. Harlozinska A; Bar JK; Richter R; Cislo M Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024 [TBL] [Abstract][Full Text] [Related]
36. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas. Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421 [TBL] [Abstract][Full Text] [Related]
38. 'Ciliated' tumour cells in ascitic fluid from two cases of cystadenocarcinoma of the ovary. Palaoro L; Rofrano J; Di Roma D; Scabuzzo M; Bedini R; Blanco AM Cytopathology; 1992; 3(3):183-90. PubMed ID: 1511123 [TBL] [Abstract][Full Text] [Related]
39. Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer. Silburn PA; Khoo SK; Hill R; Daunter B; Mackay EV Diagn Immunol; 1984; 2(1):30-5. PubMed ID: 6209058 [TBL] [Abstract][Full Text] [Related]
40. Adenosquamous-cell carcinoma of the ovary: report of a case with positive peritoneal fluid cytology. Kornacki S; Chung HR; Khan MY; Sama JC Diagn Cytopathol; 1989; 5(1):79-83. PubMed ID: 2721356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]